Search: protein_class:FDA approved drug targets AND protein_class:G-protein coupled receptors - The Human Protein Atlas

We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.

95 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 2

Gene

Gene description	x

Protein class	x

Tissue

Cell

Cancer

Subcellular location	x

RNA tissue category	x

Hydroxycarboxylic acid receptor 3

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

Hypocretin (orexin) receptor 1

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Hypocretin (orexin) receptor 2

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

HRH1

Histamine receptor H1

FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins

Plasma membrane
Cytosol

HRH2

Histamine receptor H2

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

HRH3

Histamine receptor H3

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enriched

5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled

Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins

5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Plasma membrane

Tissue enhanced

5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enriched

5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Tissue enhanced

5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enriched

HTR4

5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins

Tissue enhanced

HTR6

5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

HTR7

5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins

Nuclear speckles
Plasma membrane
Cytosol

Luteinizing hormone/choriogonadotropin receptor

Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins

MC2R

Melanocortin 2 receptor (adrenocorticotropic hormone)

Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Tissue enriched

Melatonin receptor 1A

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Tissue enhanced

Melatonin receptor 1B

FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins

Tissue enhanced

Neurotensin receptor 2

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enriched

Opioid receptor, delta 1

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

Opioid receptor, kappa 1

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Opioid receptor, mu 1

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

OXTR

Oxytocin receptor

FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins

Tissue enriched

Purinergic receptor P2Y, G-protein coupled, 12

Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enriched

Purinergic receptor P2Y, G-protein coupled, 2

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

Prostaglandin E receptor 1 (subtype EP1), 42kDa

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Tissue enhanced

Prostaglandin E receptor 2 (subtype EP2), 53kDa

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Prostaglandin E receptor 3 (subtype EP3)

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Prostaglandin E receptor 4 (subtype EP4)

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Expressed in all

Prostaglandin F receptor (FP)

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

Prostaglandin I2 (prostacyclin) receptor (IP)

FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins

Tissue enhanced

Parathyroid hormone 2 receptor

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Sphingosine-1-phosphate receptor 5

FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins

Tissue enhanced

SCTR

Secretin receptor

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Tissue enhanced

SMO

Smoothened, frizzled class receptor

Cancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins

SPECC1L-ADORA2A

SPECC1L-ADORA2A readthrough (NMD candidate)

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Tissue enhanced

Somatostatin receptor 1

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

Somatostatin receptor 2

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

Somatostatin receptor 5

FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins

Plasma membrane

Tissue enhanced

Trace amine associated receptor 1

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tachykinin receptor 1

FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Tissue enhanced

Thromboxane A2 receptor

Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins

Nuclear speckles
Plasma membrane

TSHR

Thyroid stimulating hormone receptor

Cancer-related genes
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins

Tissue enriched

« prev | Page of 2

Contact

contact@proteinatlas.org

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.